相关实验视频

Updated: Jul 19, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

当前药物和配方的进步用于治疗无氧性皮肤炎

Keerthi Atluri¹, Srikanth Manne¹, Vijendra Nalamothu¹

¹Tergus Pharma, Durham, NC 27703, USA.

Critical reviews in therapeutic drug carrier systems

|August 16, 2023

概括

这篇综述探讨了针对慢性炎症性皮肤疾病 - - 亚托皮炎 (AD) 的先进局部治疗方法. 它强调了新的药物输送策略和新兴疗法,为改善患者治疗结果提供了希望.

科学领域:

皮肤病学皮肤病学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

亚托皮炎 (AD) 是一种复杂的,复发性炎症性皮肤病,由于现有治疗方法的多样化表型和有限的疗效,其治疗具有挑战性.
了解AD的遗传,免疫和病理生理机制的近期进展刺激了新型治疗药物候选者的开发.

研究的目的:

提供当前的亚托皮性皮肤炎治疗方法的全面概述.
评估目前正在临床研究中的AD新药输送策略.
仔细检查药物无活性成分在已批准的局部AD治疗中的作用.

主要方法:

审查当前关于亚托皮性皮炎治疗的文献.
对新型药物输送策略的临床研究的分析.
检查局部治疗方法,包括软化剂,屏障修复剂,局部皮质类固醇 (TCS),化酶4 (PDE4) 抑制剂,氨酸抑制剂和氏激酶 (JAK) -STAT通路抑制剂.
讨论生物和全身疗法以及即将推出的治疗方法.

主要成果:

在AD中识别广泛的临床表型.
在临床研究中评估各种新型药物输送策略.
重点是局部治疗及其作用机制.
讨论AD的生物,系统和新兴疗法.

结论:

新型治疗药物候选药物和输送策略在治疗亚托邦性皮肤炎方面表现有前途.
对AD病理生理学的全面理解对于开发有效的治疗方法至关重要.
对局部无活性成分的进一步研究可能会优化AD治疗配方.

更多相关视频

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

相关概念视频

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Drug Delivery: Miscellaneous Routes

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...